After I have treated patients for ingrowntoenail, I suggest that they preventrecurrences by regularly filingthe central portion of the nail to keepit thin.
After I have treated patients for ingrowntoenail, I suggest that they preventrecurrences by regularly filingthe central portion of the nail to keepit thin. The nail will then begin togrow more toward the center, insteadof the sides, to compensate for theloss of thickness.
-- Adriana Pavletic, MD
Omaha
FDA Accepts Protocol for Annovis Bio’s Buntanetap Phase 3 Alzheimer Disease Trial
January 9th 2025Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.